Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Halozyme Therapeutics Inc (HALO) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Halozyme Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Halozyme Therapeutics Inc since 2005. The reporting company's ticker symbol is HALO. The reporting company's CIK number is 1159036.
The total value of stock buying since 2005 is $117,790,806.
The total value of stock sales since 2005 is $79,501,186.
The total value of stock option exercises since 2005 is $3,644,687.
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Halozyme Therapeutics Inc (HALO).
Insider trading activities including stock purchases, stock sales, and option exercises of HALO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Halozyme Therapeutics Inc (symbol HALO, CIK number 1159036) see the Securities and Exchange Commission (SEC) website.